Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $70.75 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.